Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Brazil
  4. Bolsa de Valores de Sao Paulo
  5. Ambev S.A.
  6. News
  7. Summary
    ABEV3   BRABEVACNOR1

AMBEV S.A.

(ABEV3)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Ambev S A : Earnings Release Presentation 2Q21

07/29/2021 | 10:59am EDT

2Q21 Earnings Call

July 29th, 2021

This presentation was prepared by Ambev S.A. ("Ambev" or "Company") for the exclusive use in the earnings

conference call of the second quarter of 2021 (2Q21). This presentation should not be considered as a complete

document and should be analyzed together with the Company's quarterly information form (ITR) for the second quarter and the respective press release, both available on the U.S. Securities and Exchange Commission - SEC and the CVM website. This presentation was prepared for informational purposes only and should not be considered as a solicitation or offer to buy or sell any securities of the Company, or as advice or recommendation of any nature. This presentation is not intended to be comprehensive, or to contain all the information that Ambev's shareholders might need. No decisions on investment, disposal or any other financial decisions or actions shall be made solely on the basis of the information contained herein.

This presentation segregates the impact of organic changes from those arising from changes in scope or currency

translation. Scope changes represent the impact of acquisitions and divestitures, the start up or termination of activities or the transfer of activities between segments, curtailment gains and losses and year over year changes in accounting estimates and other assumptions that management does not consider as part of the underlying performance of the business. Organic growth and normalized numbers are presented applying constant year-over- year exchange rates to exclude the impact of the movement of foreign exchange rates.

Unless stated, percentage changes in this presentation are both organic and normalized in nature. Whenever used in

this document, the term "normalized" refers to performance measures (EBITDA, EBIT, Profit, EPS) before exceptional

items adjustments. Exceptional items are either income or expenses which do not occur regularly as part of the normal activities of the Company. They are presented separately because they are important for the understanding of the underlying sustainable performance of the Company due to their size or nature. Normalized measures are additional measures used by management and should not replace the measures determined in accordance with IFRS as indicators of the Company's performance. Comparisons, unless otherwise stated, refer to the second quarter of 2020 (2Q20). Values in this presentation may not add up due to rounding.

All-time high rolling 12 months volumes…

…with strong performance of International Operations and Brazil

9 of our top 10 markets delivered volume growth vs last year

7 of our top 10 markets grew volumes ahead of 2019

Flexible and agile revenue management initiatives & premiumization

Continuing to grow BEES & ZÉ Delivery

2Q21 Beer Volume

7 Cannes Lions prizes

Beck's - "Beck's Frequency"

Guaraná - "She Can"

Corporate - "Responsible Billboards"

Quilmes - "Rewatch"

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

AmBev SA published this content on 29 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 July 2021 14:58:04 UTC.


© Publicnow 2021
All news about AMBEV S.A.
09/17AMBEV S A : NOTICE TO THE MARKET (Form 6-K)
PU
09/09AMBEV S A : CONSOLIDATED FORM (Form 6-K)
PU
09/09AMBEV S A : (X) the only transactions with securities and derivatives were those..
PU
08/27AMBEV S A : Extract of the Minutes of the Meeting of the Board of Directors of A..
PU
08/19AMBEV S A : NOTICE ON RELATED PARTIES TRANSACTIONS (Form 6-K)
PU
08/13AMBEV S A : Goldman Sachs Initiates Coverage on Ambev With Sell Rating, $2.60 Pr..
MT
08/10AMBEV S A : Report on review of interim consolidated financial statements (Form ..
PU
08/10AMBEV S A : CONSOLIDATED FORM (Form 6-K)
PU
08/10AMBEV S A : (X) the only transactions with securities and derivatives were those..
PU
07/30AMBEV : Q2 Earnings Snapshot
AQ
More news
Analyst Recommendations on AMBEV S.A.
More recommendations
Financials
Sales 2021 67 398 M 12 757 M 12 757 M
Net income 2021 10 955 M 2 073 M 2 073 M
Net cash 2021 15 735 M 2 978 M 2 978 M
P/E ratio 2021 22,8x
Yield 2021 3,23%
Capitalization 248 B 46 662 M 46 883 M
EV / Sales 2021 3,44x
EV / Sales 2022 3,20x
Nbr of Employees 50 000
Free-Float 27,9%
Chart AMBEV S.A.
Duration : Period :
Ambev S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AMBEV S.A.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 15,74 BRL
Average target price 17,64 BRL
Spread / Average Target 12,1%
EPS Revisions
Managers and Directors
Jereissati Jean Neto Chief Executive Officer
Fernando Mommensohn Tennenbaum Director
Lucas Machado Lira Chief Financial & Investor Relations Officer
Victório Carlos de Marchi Co-Chairman
Michel Dimitrios Doukeris Co-Chairman
Sector and Competitors
1st jan.Capi. (M$)
AMBEV S.A.0.58%46 662
ANHEUSER-BUSCH INBEV-14.06%113 859
HEINEKEN N.V.-0.88%61 109
CONSTELLATION BRANDS, INC.-1.92%41 161
BUDWEISER BREWING COMPANY APAC LIMITED-25.08%32 587
ASAHI GROUP HOLDINGS, LTD.30.70%25 580